Page last updated: 2024-11-05

tranexamic acid and Dermatitis, Atopic

tranexamic acid has been researched along with Dermatitis, Atopic in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
López González, G1
Parra, C1
Billene, RN1
Ortíz Medina, AH1
Grinberg, AJ1

Other Studies

1 other study available for tranexamic acid and Dermatitis, Atopic

ArticleYear
[Actinic prurigo. Treatment with antifibribolytics].
    Medicina cutanea ibero-latino-americana, 1979, Volume: 7, Issue:1-3

    Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Dermatitis, Atopic; Drug Evaluation;

1979